We investigated the effects of troglitazone, which is a ligand of nuclear transcription factor peroxisome proliferator-activated receptor-y (PPAR-y), on insulin-Ll1duced tetrahydrobiopterin (BH4) synthesis in mouse brain microvascular endothelial cells (MBMECs). BH4 content was determined as biopterin, by reversed-phase high performance liquid chromatography using fluorometric detection. Measurement of mRNA level of GTP cyclohydrolase I (GTPCH), which is a rate-limiting enzyme for de novo BH4 synthesis, was performed by reverse transcription-polymerase chain reaction (RT -PCR). Addition of insulin (10 )lg/ml) to endothelial cells increased intracellular BH4 content and GTPCH mRNA level, and the insulin-induced increase in BH4 content and GTPCH mRNA level was further stimulated by co-treatment with troglitazone (0.3-3 ~lM). However, the expression of PPAR-y mRNA in untreated and insulin-treated endothelial cells was not detected. Moreover, bezafibrate (1-10 /lM), a ligand of PPAR-o, did not affect BH4 synthesis in insulin-treated endothehal cells. These findings suggest that troglitazone stimulates insulin-induced BH4 synthesis in endothelial cells with the induction of GTPCH through PPAR-y-and PPAR-o-independent mechanism.